Book Online
or Call 1-855-SAUSALITO
Sign In
|
Register
|
About Sausalito
|
Contact Us
Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast
|
Traffic
Online Reservations
Cavallo Point
Casa Madrona
The Gables Inn
Mill Valley Inn
Acqua Hotel
Larkspur Hotel
Waters Edge
The Lodge at Tiburon
Sausalito Hotels
Vacation Packages
San Francisco Hotels
Event Calendar
Art Galleries
Arts and Culture
Amusement Parks
Nightlife
Attractions
Sausalito Ferry
Public Parks
Entertainment
Movie Show Times
TV Listings
Celebrities on TV
Museums and Historical Places
Environmental
Food and Wine
Day Trips
Visit San Francisco
Spas and Massage
Apartments
Arts, Culture, & Entertainment
Amusement and Water Parks
Art Galleries & Dealers
Art Instruction & Schools
Attractions
Environmental
Food and Wine Entertainment
Marin Arts and Culture
Movie Theaters & Movie Rentals
Museums
Music Venues
Photographers
Photography - Commercial
Automotive
Auto Glass & Detailing
Auto Repair Service
Gas Stations
New & Used Car Dealers
Boating
Boat Rides
Boat Storage
Boats & Chartered Boats
Harbors, Marinas & Yacht Clubs
Private Yacht Clubs
Business & Professional Services
Employment Agencies
Industrial Supplies & Services
Insurance Agents & Agencies
Mailing & Shipping
Photography - Commercial
Private Investigators
Rubbish & Garbage Removal
Security Systems
Self Storage
Community & City Services
Chamber of Commerce
City & County Government
City Hall
City Maps & Guides
City of Sausalito
Community Centers
Fire Department
Library
Police Department
Post Offices
State Government
Construction and Contractors
Architects
General Contractors
Home Remodeling
Landscaping
Plumbers
Education and Schools
Nursery Schools & Kindergarten
Private Schools
Public Schools
Tutoring
Financial and Legal Services
Accountants & Tax
Banks
Bookkeeping
Financial Consultants
Lawyers & Attorneys at Law
Public Notaries
Health & Child Care
Acupuncture / Alternative Medicine
Child Protective Services
Chiropractors
Day Care
Dentists
Doctors, Physicians & Surgeons
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Hypnotherapy
Medical Equipment
Physical Therapists
Psychiatrists & Therapists
Specialists
Home and Garden
Cleaning Services
Doors & Windows
Floor Coverings
Interior Design
Landscaping
Moving Companies
Pools, Spas & Saunas
Remodeling
Media
Local TV Stations
Magazine Publishers
Newspapers
Online Publications
Print Publications
Radio Stations
Nightclubs & Music
Organizations, Foundations, & Associations
Business/Professional
Charitable Foundations
Common Interest Groups
Non-Profits
Youth Organizations
Pets
Dog & Cat Grooming
Kennels & Pet Boarding
Pet Hospitals
Pet Supplies
Veterinarians
Real Estate
Apartments
Appraisers
Commercial Development
Commercial Management
Commercial Real Estate
Construction
Developers
Mortgage Brokers
Property Management
Residential Real Estate
Religion
Restaurants, Food & Bars
American
Bakery
Breakfast
Burgers
Chinese
Coffee & Caf�s
Deli
Fast Food
Free Wi-Fi
French
Himalayan
Ice Cream / Frozen Yogurt
Indian
Italian
Mexican
Ocean View Restaurants
Pizza
Seafood
Sports Bars
Steakhouse
Sushi
Thai Food
Wine Tasting Room
Salons, Spas, & Fitness
Barbers
Beauty Salons
Cosmetics
Fitness Equipment
Gyms & Health Clubs
Manicures & Pedicures
Massages
Personal Trainers
Spas
Waxing
Sausalito Hotels & Inns
Bed & Breakfasts
Hotels, Motels & Resorts
Vacation Rentals
Shopping
Book Stores
Children's Clothing
Electronics
Florists
Furniture & Appliances
Gifts & Specialty Shops
Grocery Stores
Handbags
Jewelers
Marin County Shopping Centers
Men & Women's Clothing
Men's Clothing
Shoes
Sportswear
Women's Clothing
Yoga
Sports and Recreation
Bicycle Rentals & Retailers
Boats & Chartered Boats
Kayaking
Public Parks
Walking Trails
Technology & Utility Services
Computer Parts & Supplies
Computer Repair
Electric Companies
Internet Service Providers
Telephone & Cable Companies
Website Development & Design
Travel and Transportation
Airport Transportation
Bike Rentals
Buses Charter & Rental
Ferry
Limo Car Services
Taxi Cabs
Travel Agencies
Weddings
Caterers
Planners
Venues
Wi-Fi Hotspots
Your Business Here
Ferry Schedule
Surf Report
Coupons
Contests
Classifieds
Site Forums
Photo Gallery
Story Archives
Advertise With Us
Free Email
Send Flowers
Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Aulos Bioscience
New Phase 2 Data for Aulos Bioscience’s Imneskibart Reveal Clinical Activity in Melanoma and Non-Small Cell Lung Cancer
November 07, 2025
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience to Present Updated Phase 2 Data for Imneskibart (AU-007) in Melanoma and Non-Small Cell Lung Cancer at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 03, 2025
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Presents New Phase 2 Data for AU-007 Demonstrating Continued Strong Anti-Tumor Activity in Advanced Cancers at AACR Annual Meeting
April 29, 2025
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Doses First Patient in Phase 2 Cohort Evaluating AU-007 in Combination With Nivolumab for Second-Line Treatment of Melanoma
April 14, 2025
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic AU-007 in Melanoma at AACR Annual Meeting
March 25, 2025
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Doses First Patient in Phase 2 Cohort Evaluating the Combination of Avelumab and AU-007 for the Treatment of Non-Small Cell Lung Cancer
November 27, 2024
From
Aulos Bioscience
Via
Business Wire
Strong Evidence of AU-007’s Anti-Tumor Activity in Advanced Solid Tumor Cancers Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 07, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Presents Phase 2 Dose Selection Data for Novel IL-2 Therapeutic Antibody, AU-007, at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 23, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Announces Presentation Detailing Phase 2 Dose Selection for AU-007 in Solid Tumor Treatment at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 09, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic Antibody, AU-007, at 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 04, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
May 23, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Enters Into Clinical Trial Collaboration and Supply Agreement With Merck KGaA, Darmstadt, Germany To Study Combination of Bavencio® With AU-007
May 15, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience to Present Updated Phase 1/2 Clinical Trial Results for Novel IL-2 Therapeutic AU-007 in Advanced Solid Tumor Cancers at 2024 ASCO Annual Meeting
April 24, 2024
From
Aulos Bioscience
Via
Business Wire
First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2 Antibody for Solid Tumor Cancers
January 25, 2024
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase 1/2 Study Evaluating Computationally Designed IL-2 Antibody for Treatment of Solid Tumors
December 18, 2023
From
Aulos Bioscience
Via
Business Wire
New Phase 1 Dose Escalation Data Show Well-Tolerated Safety Profile and Anti-Tumor Activity for Aulos Bioscience’s AU-007 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 03, 2023
From
Aulos Bioscience
Via
Business Wire
New Phase 1 Dose Escalation Cohorts Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic Effects at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 14, 2023
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience to Present Encouraging Pharmacodynamic Data for AU-007 From Phase 1 Dose Escalation Cohorts at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Announces Presentation of Updated Safety and Efficacy Data From First-in-Human Phase 1/2 Clinical Trial of AU-007 at 38th Society for Immunotherapy of Cancer (SITC) Annual Meeting
September 27, 2023
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Raises $20 Million in Series A Extension Financing From Apple Tree Partners
August 01, 2023
From
Aulos Bioscience
Via
Business Wire
Interim Results From Phase 1/2 Clinical Trial in Solid Tumor Cancers Demonstrate Aulos Bioscience’s AU-007 is Well Tolerated and Uniquely Reduces Regulatory T Cells
May 25, 2023
From
Aulos Bioscience
Via
Business Wire
First U.S. Patient Dosed in Aulos Bioscience’s Phase 1/2 Clinical Trial of AU-007, a Novel IL-2 Therapeutic for the Treatment of Solid Tumors
February 01, 2023
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Presents Initial Data From First-in-Human Phase 1/2 Clinical Trial of Computationally Designed Antibody AU-007 at 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Announces FDA Clearance of IND Application for AU-007, a Novel Immunotherapy for the Treatment of Solid Tumors
October 31, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience to Present Initial Safety Data From First-in-Human Phase 1/2 Clinical Trial of IL-2 Therapeutic AU-007 at 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 11, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Presents Poster on Phase 1/2 Clinical Trial of Computationally Designed IL-2 Antibody AU-007 at 2022 ASCO Annual Meeting
May 26, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Initiates Phase 1/2 Clinical Trial of IL-2 Therapeutic AU-007 for the Treatment of Solid Tumors
May 05, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Announces Presentation on First-in-Human Phase 1/2 Clinical Trial of Novel IL-2 Therapeutic AU-007 at 2022 ASCO Annual Meeting
April 27, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Announces Preclinical Data Demonstrating Ability of Novel IL-2 Therapeutic AU-007 to Eliminate Solid Tumors
March 21, 2022
From
Aulos Bioscience
Via
Business Wire
Aulos Bioscience Receives HREC Approval to Initiate First-in-Human Clinical Trial Evaluating Anti-Tumor Activity of Novel IL-2 Therapeutic AU-007
February 23, 2022
From
Aulos Bioscience
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Sausalito Home
|
Lodging
|
Sausalito Restaurants
|
Things To Do
|
Sausalito Events Calendar
|
Shopping
|
Sausalito Real Estate
|
Sausalito Directory Listings
|
Sausalito Blog
|
Jobs
|
More
Photos copyright by
Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.
